Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial
The Lancet Psychiatry
Fecha de publicación: 9 de Agosto
Autores: Dr Michael Schönenberg, PhD’Correspondence information about the author Dr Michael SchönenbergEmail the author Dr Michael Schönenberg, Eva Wiedemann, PhD, Alexander Schneidt, PhD, Jonathan Scheeff, MSc, Alexander Logemann, PhD, Philipp M Keune, PhD, Prof Martin Hautzinger, PhD.
DOI: http://dx.doi.org/10.1016/S2215-0366(17)30291-2
Background: Many studies suggest that electroencephalographic (EEG) neurofeedback might be beneficial in the treatment of attention-deficit hyperactivity disorder (ADHD). However, numbers of well controlled studies are low and neurofeedback techniques are regarded as highly controversial. The present trial examined the efficacy (compared with sham neurofeedback) and efficiency (compared with meta-cognitive therapy) of a standard EEG neurofeedback protocol in adults with ADHD.
